Revolution Medicines, Inc. (NASDAQ:RVMD) Q2 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to Revolution Medicine's Q2 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Revolution Medicines Inc. (RVMD)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Farallon Capital Thomas Steyer | 9,757,692 | $378,696,027 | +30% | 1.78% |
| 2. | Baker Bros. Advisors Julian Baker And Felix Baker | 7,569,090 | $293,756,383 | +1% | 3.75% |
| 3. | Biotechnology Value Fund / BVF Inc Mark Lampert | 5,981,212 | $232,130,838 | 6.5% | |
| 4. | Casdin Capital Eli Casdin | 4,406,875 | $171,030,819 | -22% | 13.1% |
| 5. | Woodline Partners Michael Rockefeller And Karl Kroeker | 3,290,791 | $127,715,599 | -14% | 1.21% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.85 | 6,200 | Director | 1,553,134 | 2023-03-10 | Filing | |
| $20.43 | 93,800 | Director | 1,546,934 | 2023-03-10 | Filing | |
| $22.00 | 318,181 | Director | 618,181 | 2023-03-07 | Filing | |
| $22.00 | 231,819 | Director | 1,453,134 | 2023-03-07 | Filing | |
| $20.00 | 250,000 | Director | 1,221,315 | 2022-07-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $42.98 | 16,667 | 269,073 | 2024-08-13 | Filing | ||
| $46.48 | 3,217 | 311,885 | 2024-08-01 | Filing | ||
| $45.60 | 6,783 | 315,102 | 2024-08-01 | Filing | ||
| $48.06 | 3,879 | 269,073 | 2024-07-15 | Filing | ||
| $47.02 | 3,800 | 272,952 | 2024-07-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 14,882,086 | $426,818,226 | 0.07% | |
| 2. | 14,634,391 | $419,714,333 | 0% | |
| 3. | 12,954,314 | $371,529,727 | 0% | |
| 4. | 6,296,740 | $180,590,503 | 33.64% | |
| 5. | 6,253,361 | $179,346,393 | 0% |
News See All
Revolution Medicines, Inc. (NASDAQ:RVMD) Q1 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to Revolution Medicine's First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Revolution Medicines, Inc. (NASDAQ:RVMD) Q4 2023 Earnings Call Transcript
Revolution Medicines, Inc. misses on earnings expectations. Reported EPS is $-1.14 EPS, expectations were $-0.86. Revolution Medicines, Inc.
Revolution Medicines, Inc. (NASDAQ:RVMD) Q3 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Revolution Medicines Q3 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Revolution Medicines, Inc. (NASDAQ:RVMD) Q2 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to Revolution Medicine's Second Quarter 2023 Earnings Conference Call. At this time all participants are in a listen-only mode.
Revolution Medicines, Inc. (NASDAQ:RVMD) Q1 2023 Earnings Call Transcript
Operator: Good day and welcome to Revolution Medicine's First Quarter 2023 Earnings Conference Call. As a reminder, today's conference is being recorded.
Hedge Fund and Insider Trading News: Bill Ackman, Warren Buffett, Carl Icahn, Michael Burry, Rhenman & Partners Asset Management, Oaktree Capital Management, Revolution Medicines Inc (RVMD), Grocery Outlet Holding Corp (GO), and More
Billionaire investor Bill Ackman said the US government's move to guarantee deposits in the aftermath of Silicon Valley Bank and Signature Bank's failure is not a "not a bailout in any form".
Revolution Medicines, Inc. (NASDAQ:RVMD) Q4 2022 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Revolution Medicines Q4 Year-End 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Revolution Medicines, Inc. (NASDAQ:RVMD) Q3 2022 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Revolution Medicines Third Quarter 2022 Earnings Webcast.
Harvard University Stock Portfolio: Top 10 Picks
Harvard Management Company was established in 1974 and manages Harvard University's endowment and financial assets.
Billionaire Hedge Funds
